Prostate cancer detection rates were significantly higher in patients who underwent transperineal biopsy compared to those who underwent transrectal biopsy, regardless of pre-biopsy PSA levels (p < 0.05). The gene discussed is KLK3; the disease is Familial prostate cancer.